BioSpace News Archive

Pharm Country

Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress

Celularity Inc. announced today that the Company’s Founder and CEO, Dr. Robert Hariri, M.D., Ph.D., will present the keynote lecture at the Society for Brain Mapping and Therapeutics (SBMT) Annual World Congress on March 16, 2024.

March 12, 2024
·
5 min read
Business

Alcami Partners with Tanvex CDMO to Offer a Complete Solution for Biologics Developers

Alcami Corporation (“Alcami”), a leading contract development and manufacturing organization (CDMO), today announced a new strategic partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services.

March 12, 2024
·
3 min read
Business

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Glucotrack, Inc. announced today that Vincent Wong has joined the Company as Vice President of Quality.

March 12, 2024
·
4 min read
Pharm Country

Lung Cancer Research Foundation Announces Research Grant Awards

The Lung Cancer Research Foundation (LCRF) has announced three research grant awards funded by Daiichi Sankyo and AstraZeneca, totaling $810,000.

March 12, 2024
·
2 min read
BioCapital

High Prevalence of Cognitive Impairment in Patients with Heart Failure Shown to Negatively Impact Disease Self-Management

Cognitive impairment is prevalent in patients living with heart failure and was shown to negatively impact functional abilities, life expectancy, medication management and patient self-care, a statement released by the Heart Failure Society of America (HFSA) revealed.

March 12, 2024
·
3 min read
Drug Development

Saghmos Therapeutics Announces Receipt of Notice of Allowance from Japanese Patent Office for Phase 3-Ready Cardiorenal Metabolic Modulator ST-62516

Saghmos Therapeutics, Inc. announced that it has received a Notice of Allowance from the Japanese Patent Office for a patent for its Phase 3-ready product, ST-62516.

March 12, 2024
·
3 min read
Business

Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Edwin Beale as its new Chief Commercial Officer, effective immediately.

March 12, 2024
·
2 min read
Pharm Country

Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients

Astrocyte Pharmaceuticals Inc. has announced today the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for its lead program, AST-004, for acute ischemic stroke.

March 12, 2024
·
3 min read
Business

Expert Systems Expands Partnership with Eilean Therapeutics and Joins Its Best-in-Class PTPN2 Inhibitor Program

Expert Systems, a leader in AI-enabled drug discovery, announces the expansion of the collaboration with Eilean Therapeutics as it joins its new PTPN2 inhibitor program, which Eilean has recently acquired from Ness Therapeutics Inc (Ness) in an all-equity transaction.

March 12, 2024
·
2 min read
Genetown

DOMINION DIAGNOSTICS Earns 2024 Great Place To Work Certification™

Dominion Diagnostics, a leading national medical laboratory specializing in urine drug monitoring solutions is proud to announce that it has been Certified™ by Great Place To Work® in 2024.

March 12, 2024
·
3 min read